Abstract:Background: Fetal growth restriction (FGR) occurs in 10% of pregnancies worldwide. Placenta dysfunction, as one of the most common causes of FGR, is associated with various poor perinatal outcomes. The main objectives of this study were to screen potential diagnostic biomarkers for FGR and to evaluate the function of immune cell infiltration in the process of FGR. Methods: Firstly, differential expression genes (DEGs) were identified in two Gene Expression Omnibus (GEO) datasets, and gene set enrichment analysis was performed. Diagnosis-related key genes were identified by using three machine learning algorithms (least absolute shrinkage and selection operator, random forest, and support vector machine model), and the nomogram was then developed. The receiver operating characteristic curve, calibration curve, and decision curve analysis curve were used to verify the validity of the diagnostic model. Using cell-type identification by estimating relative subsets of RNA transcripts (CIBERSORT), the characteristics of immune cell infiltration in placental tissue of FGR were evaluated and the candidate key immune cells of FGR were screened. In addition, this study also validated the diagnostic efficacy of TREM1 in the real world and explored associations between TREM1 and various clinical features. Results: By overlapping the genes selected by three machine learning algorithms, four key genes were identified from 290 DEGs, and the diagnostic model based on the key genes showed good predictive performance (AUC = 0.971). The analysis of immune cell infiltration indicated that a variety of immune cells may be involved in the development of FGR, and nine candidate key immune cells of FGR were screened. Results from real-world data further validated TREM1 as an effective diagnostic biomarker (AUC = 0.894) and TREM1 expression was associated with increased uterine artery PI (UtA-PI) (p-value = 0.029). Conclusion: Four candidate hub genes (SCD, SPINK1, TREM1, and HIST1H2BB) were identified, and the nomogram was constructed for FGR diagnosis. TREM1 was not only associated with a variety of key immune cells but also correlated with increased UtA-PI. The results of this study could provide some new clues for future research on the prediction and treatment of FGR.

Progress in the understanding of the etiology and predictability of fetal growth restriction

Fetal Growth Restriction: Does an Integrated Maternal Hemodynamic-Placental Model Fit Better?

Integrated Analysis of Key Genes and Pathways Involved in Fetal Growth Restriction and Their Associations With the Dysregulation of the Maternal Immune System

Integrated Bioinformatics Analysis to Screen Hub Gene Signatures for Fetal Growth Restriction

FGR-associated Placental Insufficiency and Capillary Angiogenesis Involves Disruptions in Human Placental Mirnas and Mrnas

The placental blood perfusion and LINC00473-mediated promotion of trophoblast apoptosis in fetal growth restriction

Early judgment of placental dysfunction and its relationship with fetal growth restriction

Decreased PGF May Contribute to Trophoblast Dysfunction in Fetal Growth Restriction.

Molecular regulators of defective placental and cardiovascular development in fetal growth restriction

Integrated Placental Modelling of Histology with Gene Expression to Identify Functional Impact on Fetal Growth

Genetics Etiologies Associated with Fetal Growth Restriction

Related Research Progress of Placenta Vascularization Disorders with Fetal Growth Restriction

Fetal growth restriction: unresolved issues of risk stratification, early diagnosis, and obstetric management

Placental thrombosis complicated with fetal growth restriction:A case report and literature review

Gut Microbiota, Inflammation, and Probiotic Supplementation in Fetal Growth Restriction—A Comprehensive Review of Human and Animal Studies

IL-27 Deficiency Inhibits Proliferation and Invasion of Trophoblasts Via the SFRP2/Wnt/β-catenin Pathway in Fetal Growth Restriction.

Dysregulation of miRNA–mRNA expression in fetal growth restriction in a caloric restricted mouse model

Association Between Placental Pathology and Early-Onset Fetal Growth Restriction: A Systematic Review

miR-1227-3p participates in the development of fetal growth restriction via regulating trophoblast cell proliferation and apoptosis

Integrated transcriptomic analysis and machine learning for characterizing diagnostic biomarkers and immune cell infiltration in fetal growth restriction

Fetal growth restriction exhibits various mTOR signaling in different regions of mouse placentas with altered lipid metabolism